AGEN Stock Eyes Best Day Ever Following Strategic Shift To Earlier Colon Cancer Treatment
Net proceeds from the financing are slated to fund a late-stage colon cancer clinical trial and potentially provide cash runway through 2031. Agenus is also shifting its main drug combination…




